Compare WIMI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WIMI | ICCM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 45.5M |
| IPO Year | 2020 | N/A |
| Metric | WIMI | ICCM |
|---|---|---|
| Price | $2.79 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 76.0K | ★ 375.3K |
| Earning Date | 01-01-0001 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $61,329,146.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | $2.03 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $0.59 |
| 52 Week High | $9.66 | $1.66 |
| Indicator | WIMI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 35.36 |
| Support Level | $2.77 | $0.67 |
| Resistance Level | $3.26 | $0.72 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 18.37 | 0.53 |
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.